Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Zealand Pharma posts smaller-than-expected Q1 loss as obesity drugs advance

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    07/05/2026 06:05
    May 7 (Reuters) - Danish drug developer Zealand Pharma ZELA.CO reported a smaller-than-expected first-quarter operating loss on Thursday, boosted by strong momentum in its obesity drug pipeline, and said it would launch a share buyback of up to $200 million.

 (Reporting by Jesus Calero and Vera Dvorakova)

 ((jesus.calero@thomsonreuters.com))

    Recent news on Zealand Pharma A/S

    See all news